Sandbox Reserved 1123: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Loïc Duffet (talk | contribs) No edit summary |
Loïc Duffet (talk | contribs) No edit summary |
||
| Line 25: | Line 25: | ||
J. Virol. May 2010 vol. 84 no. 10 5181-5190]</ref> | J. Virol. May 2010 vol. 84 no. 10 5181-5190]</ref> | ||
* Nuclear pore (certainly but not sure)<ref>[http://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwiV2fr01MzKAhWLhhoKHafGDaUQFggiMAA&url=http%3A%2F%2Fwww.nature.com%2Fnrmicro%2Fjournal%2Fv13%2Fn8%2Ffull%2Fnrmicro3503.html&usg=AFQjCNHxI2ZQfqG9K9oGRGsoomYd40gcgw HIV-1 capsid: the multifaceted key player in HIV-1 infection Nature Reviews Microbiology 13,471–483 (2015)doi:10.1038/nrmicro3503]</ref> | * Nuclear pore (certainly but not sure)<ref name="A">[http://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwiV2fr01MzKAhWLhhoKHafGDaUQFggiMAA&url=http%3A%2F%2Fwww.nature.com%2Fnrmicro%2Fjournal%2Fv13%2Fn8%2Ffull%2Fnrmicro3503.html&usg=AFQjCNHxI2ZQfqG9K9oGRGsoomYd40gcgw HIV-1 capsid: the multifaceted key player in HIV-1 infection Nature Reviews Microbiology 13,471–483 (2015)doi:10.1038/nrmicro3503]</ref> | ||
* Dynein | * Dynein | ||
* Integrase ? | * Integrase ? | ||
| Line 36: | Line 36: | ||
<Structure load='2XDE' size='300' frame='false' align='left' caption='Cristal structure of PF-3450074 with N terminal domain of HIV capsid PDB:2XDE' scene='Insert optional scene name here' />' | <Structure load='2XDE' size='300' frame='false' align='left' caption='Cristal structure of PF-3450074 with N terminal domain of HIV capsid PDB:2XDE' scene='Insert optional scene name here' />' | ||
Thank to its central role in viral infectious process (genome protection, enveloppe cohesion, uncoating, budding), HIV capsid is a very good target for antiviral drugs. As a result, many research teams are working in this way and some molecules such as PF-3450074 are very promising. | Thank to its central role in viral infectious process (genome protection, enveloppe cohesion, uncoating, budding), HIV capsid is a very good target for antiviral drugs. As a result, many research teams are working in this way and some molecules such as PF-3450074 <ref name="A"/> are very promising. | ||
By binding to a "central pocket" on P24, it was shown ''in vitro'' that this compound is inhibiting the new viruses assembly, and consequently the virus budding. | By binding to a "central pocket" on P24, it was shown ''in vitro'' that this compound is inhibiting the new viruses assembly, and consequently the virus budding. | ||
| Line 45: | Line 45: | ||
<references /> | <references /> | ||
Structural capsid image : By Thomas Splettstoesser (www.scistyle.com) (Own work) [CC BY-SA 4.0 (http://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons | Structural capsid image : By Thomas Splettstoesser (www.scistyle.com) (Own work) [CC BY-SA 4.0 (http://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons | ||
'''Capsid targeting drug''' | '''Capsid targeting drug''' | ||
Edward M. Campbell & Thomas J. Hope. HIV-1 capsid: the multifaceted key player in HIV-1 infection Nature Reviews Microbiology 13,471–483 (2015)doi:10.1038/nrmicro3503 Published online 16 July 2015 | Edward M. Campbell & Thomas J. Hope. HIV-1 capsid: the multifaceted key player in HIV-1 infection Nature Reviews Microbiology 13,471–483 (2015)doi:10.1038/nrmicro3503 Published online 16 July 2015 | ||